[Letter to Dr. Schultz from Jon Cohen]

October 31, 1990

NIAID
Vaccine Research & Development Branch
DAIDS
6303 Executive BI.
Bethesda, MD 20892
Dear Dr. Schultz,
Here is a partial list of the people I have spoken with about AIDS vaccine
research as of October 1990:

Hilary Koprowski, Wistar
Bob Gallo, NCI
Frank Volvovitz, MicroGeneSys
Janet Woodcock, FDA
Ron Desrosiers, NERPRC
Michael Murphey-Corb, DRPRC
Murray Gardner, UC Davis
Bill Morton, U of WA
Kathy Steimer, Chiron
Nancy Haigwood, Chiron
Dennis Carlo, IRC
Jonas Salk, IRC
Richard Trauger, IRC
Ron Kennedy, SWFBR
Scott Putney, Repligen
Walter Herlihy, Repligen
Alex Rich, Repligen/MIT
Paul Schimmel, Repligen/MIT
Dan Hoth, NIAID
Wayne Koff, NIAID
Mark Cochran, Miles, former
MicroGeneSys
Jon Allan, SWFBR
Alexandra Levine, USC
Katharine Munson, USC
Tony Fauci, NIAID
Bernie Moss, NIAID
Shiu-Lok Hu, Oncogen
Dennis Panicali, Applied bioT
Dani Bolognesi, Duke
Barton Haynes, Duke
Bob Redfield, WRAIR
Ed Tramont, WRAIR
Allan Goldstein, GW/Viral Tech
David Katzenstein, Stanford
Harold McClure, Yerkes
IIIII 111111II 11 1111111 11 III i llIII11 1111111II
5571095.0199.013

Jim Curran, CDC
Joe McCormick, CDC
Mike Axthelm, ORPRC
Prem Sarin, NCI
Brad Erickson, formerly MicroGeneSys
Mark Harrington, ACT UP
Brandon Fradd, market analyst
Jeff Casdin, market analyst
Wayne Fritzsche, market analyst/IRC
investor
Marcus Conant, SF physician
Neal Flynn, UC Davis
Cliff Lane, NIAID
Bob Purcell, NIAID
Al Kapikian, NIAID
Bernie Poiesz, SUNY
Milton April, NCBRP
Bill Goodwin, SWFBR
Jim Glavin, CEO of IRC
Kevin Kimberlin, IRC/investment banker
Jim Stott, MRC
Hans Wigzell, Karolinska
Scott Layne, Los Alamos
Paul Naylor, GW
Josef Mannhalter, ImmunoAG
Joe Gibbs, NINDS
Larry Arthur, PRI/NCI
Emilio Emini, Merck
Patricia Fultz, U of Al
Kai Krohn, U of Tampere
Avi Shafferman, IIBR
Jerry Quinnan, FDA
Chris Tsoukas, McGill U
Phil Berman, Genentech
June Osborn, U of Mich
Maurizio Zanetti, UCSD